US2016228235A1PendingUtilityA1

Reinforced Biological Tissue

Assignee: LIFECELL CORPPriority: May 9, 2006Filed: Apr 21, 2016Published: Aug 11, 2016
Est. expiryMay 9, 2026(expired)· nominal 20-yr term from priority
A61L 27/58A61L 27/3645A61L 2430/10A61F 2230/0069A61L 27/3662A61L 2420/00A61L 27/18A61L 2300/606A61F 2002/0858A61F 2230/0019A61F 2/08A61L 2400/18A61F 2/0805A61L 27/28A61L 27/00A61F 2/02A61L 27/3683A61L 2430/34A61L 27/40A61F 2/0811
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides for an implantable medical device comprising a hybrid composite material including a first biological component such as an acellular tissue matrix and a second non-biological component for strengthening the device after implantation.

Claims

exact text as granted — not AI-modified
1 . A method of treatment, comprising:
 identifying an implant site of a patient with a ligament, tendon, or soft tissue structure defect;   providing a composite material to the implant site to regenerate the ligament, tendon, or soft tissue structure defect, the composite material including (i) a sheet of an acellular tissue matrix, and (ii) a non-biological component including an upper portion and a lower portion, and a neck portion between the upper portion and the lower portion, the sheet of the acellular tissue matrix wrapping around the neck portion of the non-biological component between the upper portion and the lower portion and covering at least a portion of a surface of the non-biological component to form an elongated composite having a predetermined target load capacity approximating the load capacity of a native human ligament, tendon, or soft tissue structure to be replaced by the elongated composite;   providing one or more anchors to secure the composite material to the implant site; and   anchoring the composite material to the implant site with the one or more anchors.   
     
     
         2 . The method of  claim 1 , wherein the upper portion of the non-biological component is folded over in the direction of the lower portion of the non-biological component to overlap a portion of the wrapped sheet of the acellular tissue matrix with the non-biological component while maintaining a central portion of the wrapped sheet of the acellular tissue matrix exposed between the upper and lower portions of the non-biological component. 
     
     
         3 . The method of  claim 1 , wherein the lower portion of the non-biological component is folded over in the direction of the upper portion of the non-biological component to overlap a portion of the wrapped sheet of the acellular tissue matrix with the non-biological component while maintaining a central portion of the wrapped sheet of the acellular tissue matrix exposed between the upper and lower portions of the non-biological component. 
     
     
         4 . The method of  claim 1 , wherein the non-biological component has a higher tensile load capacity than the sheet of the acellular tissue matrix at the time of implantation. 
     
     
         5 . The method of  claim 4 , wherein the sheet of the acellular tissue matrix has a higher load capacity than the non-biological component after implantation and following growth of native cells within the acellular tissue matrix. 
     
     
         6 . The method of  claim 5 , wherein a load capacity of the composite material is within a target load capacity range at the time of implantation and also following growth of the native cells within the acellular tissue matrix. 
     
     
         7 . The method of  claim 1 , comprising allowing growth of native cells within the acellular tissue matrix after implantation of the composite material. 
     
     
         8 . The method of  claim 1 , maintaining a load capacity of the composite material within a target load capacity range at the time of implantation and following growth of native cells within the acellular tissue matrix. 
     
     
         9 . The method of  claim 1 , wherein the one or more anchors include one or more interference screws. 
     
     
         10 . The method of  claim 9 , comprising inserting the one or more interference screws into a core of the composite material. 
     
     
         11 . The method of  claim 10 , comprising anchoring the composite material to the implant site with the one or more interference screws from inside of the composite material. 
     
     
         12 . The method of  claim 1 , wherein the at least one sheet of acellular tissue matrix overlays the non-biological component. 
     
     
         13 . The method of  claim 1 , wherein the non-biological component comprises a bioabsorbable polymer. 
     
     
         14 . The method of  claim 1 , wherein the non-biological component comprises a biocompatible metal. 
     
     
         15 . The method of  claim 1 , wherein the non-biological component comprises polyhydroxybutyrate, polyactic acid, polyactideglycolide acid, polydioxanone or polycaprolactone. 
     
     
         16 . The method of  claim 1 , wherein the non-biological component is a textile in the form of a knit, a weave, a braid, a nonwoven structure, or a combination of knit, weave, braid or nonwoven structures. 
     
     
         17 . The method of  claim 16 , wherein the non-biological component comprises a monofilament of non-biological material. 
     
     
         18 . The method of  claim 16 , wherein the non-biological component comprises a braided or spun multifilament yarn. 
     
     
         19 . The method of  claim 16 , wherein the sheet of the acellular tissue matrix is integrated into the textile structure of the non-biological component. 
     
     
         20 . The method of  claim 1 , wherein the composite material forms a sheet, a cylinder, a solid tube, a hollow tube, or a rolled sheet.

Join the waitlist — get patent alerts

Track US2016228235A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.